Bokemeyer, Bernd http://orcid.org/0000-0003-2016-6991
Picker, Nils http://orcid.org/0000-0001-5328-4332
Kromer, Daniel http://orcid.org/0000-0002-0770-6247
Rosin, Ludger
Patel, Haridarshan http://orcid.org/0000-0002-1827-5163
Funding for this research was provided by:
Galápagos
Article History
Accepted: 3 April 2023
First Online: 8 May 2023
Declarations
:
: The retrospective chart review was approved by the Ethics Committee of the Faculty of Medicine at the University of Rostock (approval reference number A 2020–0223). Given that the study addressed an anonymized data set, no informed consent of patients was required. The study protocol was reviewed and approved by a scientific steering committee consisting of the study sponsor, the research organization conducting the analysis, and one independent gastroenterologist.
: Bernd Bokemeyer received consultancy fees and speaking fees from AbbVie, Arena, Biogen, Celgene, Celltrion, Falk, Ferring, Galapagos Biopharma Deutschland GmbH, Janssen, MSD, Pfizer and Takeda. Nils Picker and Daniel Kromer are employees of Ingress-Health; the work of Ingress-Health in this study was funded by Galapagos NV. Ludger Rosin is an employee of Galapagos Biopharma Deutschland GmbH. Haridarshan Patel is a former employee of Galapagos NV.